STING1 and cancer: Hyperactivation of the cGAS-STING pathway contributes to autoimmune illnesses, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and Aicardi-Goutieres syndrome (AGS), as well as other conditions such as cancer (45, 46).